Study Human Digital Support Transitional Care

NCT ID: NCT06354166

Last Updated: 2024-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-30

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare the effectiveness of Divomed in organising complex hospital discharges with a conventional organisation. Effectiveness will be assessed by reducing the length of stay of patients in geriatric short-stay care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an interventional, randomised (ratio 1:1), single-centre, open-label study evaluating Divomed, a digital tool combined with human coordination, to speed up the discharge of people aged over 75 from unscheduled short-stay geriatric hospital admissions to their homes.

The study population will be patients aged 75 or over, admitted for short term unscheduled geriatric hospitalisation and eligible for discharge home.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Interventional, randomised (1:1 ratio), single-centre study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

open-label study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Divomed digital tool combined with human coordination

A digital tool combined with human coordination (Divomed) to organise discharge home from the start of hospitalisation. The digital application will be interconnected with the patient's medical file.

Group Type EXPERIMENTAL

Unscheduled hospital admissions

Intervention Type PROCEDURE

Unscheduled short-stay geriatric hospitalisations of people aged over 75 to their homes

Control Group

The control group corresponds to the organisation of conventional hospital discharge from the geriatric short-stay department.

The digital application will be interconnected with the patient's medical file.

Group Type ACTIVE_COMPARATOR

Unscheduled hospital admissions

Intervention Type PROCEDURE

Unscheduled short-stay geriatric hospitalisations of people aged over 75 to their homes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unscheduled hospital admissions

Unscheduled short-stay geriatric hospitalisations of people aged over 75 to their homes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 75 years ;
* Unplanned hospitalisation from emergency, transfers from other inpatient departments or outpatient medicine;
* Patient eligible for short-stay geriatric hospitalisation estimated to last at least 10 days;
* Patient eligible for a return home;
* Patients who have been informed and have signed an informed consent form. If necessary (for cognitive or other reasons), the information must be given to a third party, i.e. the patient's legal representative or trusted person (independent of the investigator and the sponsor), who may be asked to sign or co-sign the informed consent form (depending on the patient's vulnerability).

Exclusion Criteria

* Patients scheduled for transfusion, iron infusion or colonoscopy;
* Patients in palliative care;
* Geographical area other than department 37;
* Planned discharge from hospital to a residential establishment for dependent elderly people or to follow-up and rehabilitation care or long-term care units;
* Patient or deprived of liberty by judicial or administrative decision ;
* Patient participating in or being excluded from another clinical trial;
* Patients not covered by a social security scheme.
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Divoluci

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU de Tours - Hôpital Bretonneau

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wassim GANA

Role: CONTACT

247474747 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wassim GANA, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A02745-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.